Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

Yusuf, S ; Teo, K ; Anderson, C ; Pogue, J ; Dyal, L ; Copland, I ; Schumacher, H ; Dagenais, G ; Sleight, P

The Lancet (British edition), 2008-09, Vol.372 (9644), p.1174-1183 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível